82 related articles for article (PubMed ID: 1913648)
1. Human carcinoid cell production of paracrine growth factors that can stimulate fibroblast and endothelial cell growth.
Beauchamp RD; Coffey RJ; Lyons RM; Perkett EA; Townsend CM; Moses HL
Cancer Res; 1991 Oct; 51(19):5253-60. PubMed ID: 1913648
[TBL] [Abstract][Full Text] [Related]
2. Novel action of transforming growth factor beta 1 in functioning human pancreatic carcinoid cells.
Ishizuka J; Beauchamp RD; Sato K; Townsend CM; Thompson JC
J Cell Physiol; 1993 Jul; 156(1):112-8. PubMed ID: 8391003
[TBL] [Abstract][Full Text] [Related]
3. Expression of growth factor peptides and their receptors in neuroendocrine tumors of the digestive system.
Chaudhry A; Funa K; Oberg K
Acta Oncol; 1993; 32(2):107-14. PubMed ID: 8391829
[TBL] [Abstract][Full Text] [Related]
4. Basic fibroblast growth factor inhibits basal and transforming growth factor-beta induced collagen alpha 2(I) gene expression in scleroderma and normal fibroblasts.
Ichiki Y; Smith EA; LeRoy EC; Trojanowska M
J Rheumatol; 1997 Jan; 24(1):90-5. PubMed ID: 9002017
[TBL] [Abstract][Full Text] [Related]
5. Evidence for transforming growth factor-beta expression in human leptomeningeal cells and transforming growth factor-beta-like activity in human cerebrospinal fluid.
Johnson MD; Gold LI; Moses HL
Lab Invest; 1992 Sep; 67(3):360-8. PubMed ID: 1328762
[TBL] [Abstract][Full Text] [Related]
6. Differential growth factor expression in transformed mouse NIH-3T3 cells.
Ciardiello F; Valverius EM; Colucci-D'Amato GL; Kim N; Bassin RH; Salomon DS
J Cell Biochem; 1990 Jan; 42(1):45-57. PubMed ID: 1967612
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of transforming growth factor-beta s and transforming growth factor-beta type II receptor in the synovial tissues of patients with rheumatoid arthritis.
Taketazu F; Kato M; Gobl A; Ichijo H; ten Dijke P; Itoh J; Kyogoku M; Rönnelid J; Miyazono K; Heldin CH
Lab Invest; 1994 May; 70(5):620-30. PubMed ID: 8196359
[TBL] [Abstract][Full Text] [Related]
8. Production of transforming growth factors by human colon cancer lines.
Coffey RJ; Shipley GD; Moses HL
Cancer Res; 1986 Mar; 46(3):1164-9. PubMed ID: 3002610
[TBL] [Abstract][Full Text] [Related]
9. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
Herman ME; Katzenellenbogen BS
Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
[TBL] [Abstract][Full Text] [Related]
10. 1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells.
Koli K; Keski-Oja J
Cancer Res; 1995 Apr; 55(7):1540-6. PubMed ID: 7882362
[TBL] [Abstract][Full Text] [Related]
11. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM
Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia regulates basal and induced DNA synthesis and collagen type I production in human cardiac fibroblasts: effects of transforming growth factor-beta1, thyroid hormone, angiotensin II and basic fibroblast growth factor.
Agocha A; Lee HW; Eghbali-Webb M
J Mol Cell Cardiol; 1997 Aug; 29(8):2233-44. PubMed ID: 9281454
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of fibronectin production by TGF-beta 1 is independent of effects on cell proliferation: the example of bovine adrenocortical cells.
Shi DL; Savona C; Chambaz EM; Feige JJ
J Cell Physiol; 1990 Oct; 145(1):60-8. PubMed ID: 2211844
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
15. Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells.
Vitale G; van Koetsveld PM; de Herder WW; van der Wansem K; Janssen JA; Colao A; Lombardi G; Lamberts SW; Hofland LJ
Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E559-66. PubMed ID: 19141687
[TBL] [Abstract][Full Text] [Related]
16. Effect of transforming growth factor-beta on the insulin-like growth factor-I autocrine/paracrine axis in cultured rat articular chondrocytes.
Tsukazaki T; Usa T; Matsumoto T; Enomoto H; Ohtsuru A; Namba H; Iwasaki K; Yamashita S
Exp Cell Res; 1994 Nov; 215(1):9-16. PubMed ID: 7525324
[TBL] [Abstract][Full Text] [Related]
17. Angiostatic role of astrocytes: suppression of vascular endothelial cell growth by TGF-beta and other inhibitory factor(s).
Behzadian MA; Wang XL; Jiang B; Caldwell RB
Glia; 1995 Dec; 15(4):480-90. PubMed ID: 8926041
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factors produced by normal and neoplastically transformed rat liver epithelial cells in culture.
Liu C; Tsao MS; Grisham JW
Cancer Res; 1988 Feb; 48(4):850-5. PubMed ID: 3276400
[TBL] [Abstract][Full Text] [Related]
19. Stromal influences on transformation of human mammary epithelial cells overexpressing c-myc and SV40T.
Valverius EM; Ciardiello F; Heldin NE; Blondel B; Merlo G; Smith G; Stampfer MR; Lippman ME; Dickson RB; Salomon DS
J Cell Physiol; 1990 Nov; 145(2):207-16. PubMed ID: 2174061
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor-mediated autocrine and paracrine stimulation of human transitional cell carcinoma.
Gleave ME; Hsieh JT; Wu HC; Hong SJ; Zhau HE; Guthrie PD; Chung LW
Cancer Res; 1993 Nov; 53(21):5300-7. PubMed ID: 8221665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]